OS Therapies (OSTX)
NYSE: OSTX
· Real-Time Price · USD
2.10
0.04 (1.94%)
At close: Aug 18, 2025, 10:56 AM
OS Therapies Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -8.88M | -7.36M | -6.46M | -7.4M | -7.79M | -8.88M | -8.27M | -8.12M | -6.28M | -3.72M | -2.36M |
Depreciation & Amortization | 341.07K | 552.91K | 217.94K | 1.05M | 1.67M | 2.08M | 2.33M | 2.38M | 1.76M | 1.13M | 885.78K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 923.69K | 726.75K | 916.99K | 626.21K | 669.65K | 639.62K | 570.49K | 760.22K | 520.4K | 401.53K | 215.37K |
Other Non-Cash Items | 507.06K | 340.97K | 2.22M | 2.58M | 2.57M | 2.64M | 1.62M | 1.39M | 827.98K | 544.15K | 577.79K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -129.64K | -216.68K | 729.76K | 526.34K | 528.32K | 498.3K | 570.49K | 760.22K | 520.4K | 401.53K | 215.37K |
Operating Cash Flow | -7.28M | -5.78M | -3.27M | -3.22M | -3.01M | -3.66M | -3.74M | -3.59M | -3.17M | -1.64M | -681.62K |
Capital Expenditures | n/a | 19.00 | 19.00 | n/a | n/a | -19 | -19 | -7.1K | -7.1K | -7.1K | -7.1K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 19.00 | 19.00 | 19.00 | 1.16K | 1.15K | 1.15K | 1.15K | n/a | n/a | n/a |
Investing Cash Flow | n/a | 19.00 | 19.00 | n/a | 1.15K | 1.13K | 1.13K | -5.96K | -7.1K | -7.1K | -7.1K |
Debt Repayment | 1.5M | 2.57M | 3.65M | 3.23M | 3.16M | 3.98M | 4.04M | 4.11M | 3.33M | 1.44M | 555.63K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 11.28M | 5.05M | -329.67K | -267.97K | -284.18K | -345.26K | -323.67K | -311.25K | -147.02K | 90K | 50K |
Financial Cash Flow | 12.78M | 7.62M | 3.32M | 2.97M | 2.87M | 3.63M | 3.72M | 3.8M | 3.19M | 1.53M | 605.63K |
Net Cash Flow | 5.49M | 1.84M | 45.7K | -254.98K | -132.5K | 16.06K | 13.31K | 400.09K | 216.36K | 44.88K | 80.79K |
Free Cash Flow | -7.28M | -5.78M | -3.27M | -3.22M | -3.01M | -3.66M | -3.74M | -3.6M | -3.17M | -1.65M | -688.72K |